Dry Powder Inhaler Acoustic Monitoring for Flow and Deaggregation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Dry powder inhalers (DPIs) face challenges with insufficient patient inhalation flow rates leading to reduced dose delivery and incomplete deaggregation of powdered drugs, as they rely on patient-generated force for breaking up the powder into small enough particles to reach the lungs, and existing monitoring technologies do not effectively assess inspiratory flow and deagglomerator activation in DPIs with deagglomerator systems like the cyclone design.
Innovation Solution
Integration of a microphone with a preamplifier on the DPI to process acoustic signals and determine operating conditions, such as inspiratory flow rates and deagglomerator activation, using algorithms to ensure accurate delivery of the intended dose, particularly for patients with respiratory diseases like asthma or COPD, by analyzing airflow profiles and providing real-time feedback.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If DPIs rely on patient-generated inhalation force for deaggregation, then the device structure remains simple and portable, but insufficient patient inhalation flow rates lead to reduced dose delivery and incomplete deaggregation
Solution Approach 1:
The deagglomerator system is pre-configured with a specific geometry (vortex chamber with tangential air inlets) that will automatically generate the necessary deaggregation action when air flows through it, eliminating the need for the patient to generate excessive flow rates. The system prepares the powder for delivery in advance by breaking up agglomerates before they reach the patient's airways.
Solution Approach 2:
The invention changes the operational parameters of the DPI by introducing a deagglomerator system that operates effectively at lower inhalation flow rates. The vortex chamber geometry and air inlet configuration are designed to create optimal deaggregation conditions at typical patient inhalation flows, transforming the device from one requiring high patient effort to one that works effectively at normal inhalation rates.
2Reliability
If a deagglomerator system is added to improve powder deaggregation, then dose delivery is improved, but the device complexity increases
Solution Approach 1:
The deagglomerator system serves multiple functions within a single integrated structure: it deaggregates powder, conditions the airflow, and prepares the medicament for delivery. The vortex chamber with tangential air inlets performs deaggregation while also mixing and transporting the powder, eliminating the need for separate components for each function.
Solution Approach 2:
The deagglomerator system uses optimized geometric parameters (vortex chamber dimensions, air inlet angles and positions) to achieve effective deaggregation with minimal structural complexity. By carefully selecting these parameters, the system achieves high deaggregation efficiency without requiring complex mechanical moving parts or multiple components.
3Measurement precision
If acoustic monitoring is implemented to assess inspiratory flow and deagglomerator activation, then delivery accuracy is improved, but the device complexity and cost increase
Solution Approach 1:
The invention replaces complex mechanical flow measurement systems with acoustic monitoring. Instead of using mechanical sensors, moving parts, or electronic flow meters, the system uses a microphone to detect acoustic signals generated by the airflow through the deagglomerator. This substitution significantly reduces device complexity while maintaining measurement precision.
Solution Approach 2:
The acoustic signal serves as an intermediary that indirectly measures inspiratory flow and deagglomerator activation without requiring direct contact with the airflow or the powder. The microphone detects sound waves generated by the air-powder interaction in the vortex chamber, providing information about flow rates and deaggregation effectiveness through this acoustic mediator.
4Reliability
If the deagglomerator system is designed with specific vortex chamber geometry, then deaggregation efficiency is improved, but manufacturing precision requirements increase
Solution Approach 1:
The invention optimizes the geometric parameters of the vortex chamber (dimensions, inlet angles, curvature radii) to achieve effective deaggregation within a reasonable manufacturing tolerance range. By selecting parameters that are not overly critical, the system maintains high deaggregation efficiency while being manufacturable with standard precision capabilities.
Solution Approach 2:
The deagglomerator system can be manufactured as an integrated component using composite materials or multi-material molding techniques, allowing the vortex chamber and air inlets to be formed as a single piece with built-in geometric features. This approach reduces assembly steps and maintains geometric precision while simplifying manufacturing.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution enables precise monitoring and confirmation of drug delivery, ensuring the intended dose is inhaled effectively, even in patients with limited inspiratory flow, by accurately determining inspiratory flow rates and deagglomerator activation, thus improving DPI performance and user feedback.
Implementation Method 1
a microphone mounted on the external surface of the body of said inhaler, and a processing circuitry for processing an acoustic signal obtained from said microphone to determine operating conditions of the dry powder inhaler
Implementation Method 2
a deagglomerator system for deagglomerating the powdered drug, having a body with a mouthpiece and provided with a deagglomerator system for deagglomerating the powdered drug, characterized by a vortex chamber having an opening for the supply of the powdered medicament, two air inlets for directing air tangentially into the vortex chamber
Data Source
AI summary
Drug delivery devices are described that include a microphone and processing circuitry that can detect operating events, such as peak inspiratory flow (PIF) and Breath Actuated Mechanism (BAM) in dry powder inhalers. This information can be used to improve clinical trials by providing information about the way in which the inhalers under test are being used.